Assessment of Nanobiotechnology-Targeted siRNA Designed to inhibit NF-kappaB Classical and Alternative Signaling in Breast Tumor Macrophages
Abstract
Macrophages have been proposed as a potential target for manipulation of the microenvironment in breast cancer because they are potent effectors of the immune system. NF-kappaB (NF-kB) signaling in macrophages contributes to their impact during breast tumorigenesis. Thus, macrophage-targeted modulation of NF-kappaB has potential as a novel therapeutic approach for breast cancer. NF-kappaB signaling is mediated via two major pathways, the canonical/classical pathway and the alternative pathway.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2013
- Accession Number
- ADA601998
Entities
People
- Fiona E. Yull
- Ryan Ortega
Organizations
- Vanderbilt University